Benefits
Female Libido Support (Combination Product)
The Waynberg/Brewer 2000 study (n=202 healthy women with low sex drive) found a Muira Puama + Ginkgo biloba combination (Herbal vX) significantly improved self-reported sexual function scores in 65% of participants after 1 month. Limitation: combination product, no active comparator, single non-blinded trial. Cannot isolate muira puama's contribution from ginkgo's effects.
Erectile Dysfunction (Older Limited Trials)
Waynberg's 1990s French studies reported muira puama extract (1.5 g/day) improved ED symptoms in 51% of men and increased libido in 62% over 2 weeks. Limitations: trials were not published in peer-reviewed PubMed-indexed journals, lacked rigorous controls, and have not been independently replicated. Modern evidence-based reviews (Mazaro-Costa 2010, Srivatsav 2020) note muira puama's literature is sparse and often anecdotal.
Animal-Model Antifatigue and Adaptogenic Effects
Animal studies (Piato 2010 et al.) suggest muira puama has antistress effects, improves CNS performance under stress, and may have neuroprotective properties via mAChR cholinergic system modulation. Underlies traditional 'tonic' use for fatigue, nervous exhaustion, and convalescence. Human translation is limited.
Possible PDE5-Independent Erection Mechanism (Animal)
Mazaro-Costa 2015 rat study with muira puama + ginger + guaraná + L-citrulline combination showed effects similar to tadalafil in delaying age-related erectile dysfunction. Mechanism appears distinct from PDE5 inhibition, possibly involving NO synthase preservation. Translation to human therapy not established.
Traditional Antirheumatic and Tonic Use
Indigenous Amazonian use covers neuromuscular problems, rheumatism, GI/cardiac asthenia, prevention of baldness, and general 'strength' tonic. European herbal medicine adopted muira puama as antirheumatic, aphrodisiac, and nervous system tonic. Traditional use exceeds modern RCT evidence base.
Mechanism of action
Cholinergic / mAChR Modulation
Animal studies suggest muira puama affects muscarinic acetylcholine receptors (mAChR), providing a potential mechanistic basis for traditional CNS tonic effects and possible cognitive/sexual function impact. Mechanism is incomplete and based primarily on rodent data.
Sterol-Mediated Hormonal Modulation
β-Sitosterol, lupeol, and other plant sterols in muira puama may have weak hormonal effects (5α-reductase inhibition, mild estrogenic/androgenic activity). Common to many 'aphrodisiac' herbs but rarely the primary mechanism — relevant for traditional use claims rather than confirmed sexual function effects.
Antistress / Neuroprotective Activity (Animal)
Piato 2010 et al. demonstrated antistress effects in mice (forced swim, tail suspension). Mechanism may involve glucocorticoid axis modulation and antioxidant defense. Provides mechanistic plausibility for the traditional 'tonic' claim and possible mood support, though human data is essentially absent.
Antimicrobial and Antioxidant Activity (In Vitro)
Oliveira 2013 and others demonstrated antimicrobial activity against various pathogens and free radical scavenging activity. These broad bioactivities are common to many plant extracts and don't directly explain the libido/aphrodisiac claims, but contribute to traditional 'general health tonic' framing.
Possible Vasodilatation
Mechanistic theories propose mild vasodilatation contributing to erectile function via increased penile blood flow. Direct vascular pharmacology evidence specifically for muira puama is sparse. Most apparent effects in animal studies have used combination products, complicating mechanism attribution.
Clinical trials
Open-label clinical trial of Herbal vX, a commercial supplement combining Muira puama and Ginkgo biloba. 1-month treatment. Self-assessment questionnaires for sexual function before and after intervention. (Waynberg, Brewer 2000, Adv Ther)
202 healthy pre- and postmenopausal women complaining of low sex drive.
Significantly higher average total sexual function scores in 65% of the sample after 1 month of treatment. Specifically, 65% reported increased frequency and intensity of sexual thoughts, improved orgasm. **Limitations**: combination product (cannot isolate muira puama effect from ginkgo); no placebo control; subjective self-report measures. Promising but methodologically weak signal.
About this ingredient
Muira Puama (Ptychopetalum olacoides), known locally as 'marapuama' or 'potency wood,' is a flowering tree native to the Amazon rainforest of Brazil. The bark and roots are used medicinally. The plant has a complex phytochemistry including muirapuamine (a unique alkaloid), β-sitosterol, lupeol, coumarin, essential oils (β-caryophyllene, α-pinene, β-pinene, eugenol, camphene, limonene), and free fatty acids.
Indigenous Amazonian peoples have used muira puama for centuries as a sexual tonic, neurotonic, antirheumatic, and treatment for GI complaints. EVIDENCE: Genuinely sparse. The Waynberg/Brewer 2000 women's libido trial (n=202) is the strongest published human evidence — and it is a combination product, not pure muira puama.
The Waynberg ED trials from the 1990s have been widely cited but remain non-peer-reviewed. Animal studies provide mechanistic plausibility (antistress, mAChR effects, NO synthase preservation in combination products). Modern evidence-based reviews (Srivatsav 2020 et al.) consistently describe the literature as 'limited' and call for high-quality RCTs.
SAFETY: Generally good in traditional use, but modern human safety data is sparse. NOT a substitute for evidence-based ED therapy (PDE5 inhibitors). Clinical-grade evidence for libido/sexual function is genuinely thin, and any product claims should be viewed accordingly.